Oxford Drug Design - o2h Ventures

Oxford Drug Design is an innovative biotechnology company spun out from Professor Graham Richards’ group at the University of Oxford.The company has developed rapid, stateof-the-art virtual screening and ligand analogue searching technologies.

Building on this platform, the company is now applying machine learning techniques such as neural networks and topological data analysis to help further the drug discovery process. Utilising this technology, the company has developed a number of novel antibiotics programmes.

Designing novel antibiotics

aaRS enzymes play a key role in protein synthesis within all organisms

Histidine Kinase technology is also enabling us to tackle veterinary pathogens

Status	Active
Website	https://www.oxforddrugdesign.com/
Category	AI
Modality	Digital & Small Molecule
Headquaters	Oxford, UK
Partner	CARB-x, Innovate UK
Investment Portfolio	Fund Investment
Co-Investors	IP Group PLC, Meltwind, Business Angels

related news

Jun 18 2019

Oxford Drug Design recieves over £8m in grant and equity investment

ventures

May 31 2017

o2h ventures update: Oxford Drug Design secures £1.5M financing

ventures

Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk

What are the key risks?

• If the business you invest in fails, you are likely to lose 100% of the money you invest. Most start-up businesses fail.

2 – You are unlikely to be protected if something goes wrong

• Protection from the Financial Services Compensation Scheme (FSCS), in relation to claims against failed regulated firms, does not cover poor investment performance. Try the FSCS investment protection checker here. (https://www.fscs.org.uk/check/investment-protection-checker)

• Protection from the Financial Ombudsman Service (FOS) does not cover poor investment performance. If you have a complaint against an FCA-regulated firm, FOS may be able to consider it. Learn more about FOS protection here. (https://www.financial-ombudsman.org.uk/consumers)

3 – You won’t get your money back quickly

• Even if the business you invest in is successful, it may take several years to get your money back. You are unlikely to be able to sell your investment early.

• The most likely way to get your money back is if the business is bought by another business or lists its shares on an exchange such as the London Stock Exchange. These events are not common.

• If you are investing in a start-up business, you should not expect to get your money back through dividends. Start-up businesses rarely pay these.

4 – Don’t put all your eggs in one basket

• Putting all your money into a single business or type of investment for example, is risky. Spreading your money across different investments makes you less dependent on any one to do well.

• A good rule of thumb is not to invest more than 10% of your money in high-risk investments (https://www.fca.org.uk/investsmart/5-questions-ask-you-invest)

5 – The value of your investment can be reduced

• The percentage of the business that you own will decrease if the business issues more shares. This could mean that the value of your investment reduces, depending on how much the business grows. Most start-up businesses issue multiple rounds of shares.

• These new shares could have addition rights that your shares don’t have, such as the right to receive a fixed dividend, which could further reduce your chances of getting a return on your investment.

If you are interested in learning more about how to protect yourself, visit the FCA’s website here (https://www.fca.org.uk/investsmart)